MyMedR

Displaying all 10 publications

Abstract:

Sort:

Inclusion controlled lanthanide-imidazolium functionalised carboxylate complexation

Ling I, Alias Y, Skelton BW, Raston CL

Dalton Trans, 2012 Apr 28;41(16):4884-9.
PMID: 22398440 DOI: 10.1039/c2dt12410f

Imidazolium functionalized carboxylic acid forms a multi-component material with p-sulfonatocalix[4]arene and aquated lanthanide ions, stabilising dinuclear metal complexes for Y(3+) and Gd(3+). These have the simplest binding of two bridging carboxylates between the two metal centres (Y(3+)), or the same arrangement along with the simplest binding of one carboxylate bridging two metal ions for the larger metal ion (Gd(3+)).
Selective binding of pyrene in subdomain IB of human serum albumin: Combining energy transfer spectroscopy and molecular modelling to understand protein binding flexibility

Ling I, Taha M, Al-Sharji NA, Abou-Zied OK

Spectrochim Acta A Mol Biomol Spectrosc, 2018 Apr 05;194:36-44.
PMID: 29316482 DOI: 10.1016/j.saa.2018.01.005

The ability of human serum albumin (HSA) to bind medium-sized hydrophobic molecules is important for the distribution, metabolism, and efficacy of many drugs. Herein, the interaction between pyrene, a hydrophobic fluorescent probe, and HSA was thoroughly investigated using steady-state and time-resolved fluorescence techniques, ligand docking, and molecular dynamics (MD) simulations. A slight quenching of the fluorescence signal from Trp214 (the sole tryptophan residue in the protein) in the presence of pyrene was used to determine the ligand binding site in the protein, using Förster's resonance energy transfer (FRET) theory. The estimated FRET apparent distance between pyrene and Trp214 was 27Å, which was closely reproduced by the docking analysis (29Å) and MD simulation (32Å). The highest affinity site for pyrene was found to be in subdomain IB from the docking results. The calculated equilibrium structure of the complex using MD simulation shows that the ligand is largely stabilized by hydrophobic interaction with Phe165, Phe127, and the nonpolar moieties of Tyr138 and Tyr161. The fluorescence vibronic peak ratio I1/I3 of bound pyrene inside HSA indicates the presence of polar effect in the local environment of pyrene which is less than that of free pyrene in buffer. This was clarified by the MD simulation results in which an average of 5.7 water molecules were found within 0.5nm of pyrene in the binding site. Comparing the fluorescence signals and lifetimes of pyrene inside HSA to that free in buffer, the high tendency of pyrene to form dimer was almost completely suppressed inside HSA, indicating a high selectivity of the binding pocket toward pyrene monomer. The current results emphasize the ability of HSA, as a major carrier of several drugs and ligands in blood, to bind hydrophobic molecules in cavities other than subdomain IIA which is known to bind most hydrophobic drugs. This ability stems from the nature of the amino acids forming the binding sites of the protein that can easily adapt their shape to accommodate a variety of molecular structures.
Site specific Co(III) sarcophagine binding in multi-component phosphonium and p-sulfonatocalix[4]arene systems

Ling I, Alias Y, Sobolev AN, Skelton BW, Raston CL

Dalton Trans, 2011 Oct 28;40(40):10337-44.
PMID: 21776527 DOI: 10.1039/c1dt10550g

Co(III) sarcophagine-type cage molecules, [Co(diCLsar)](3+) or [Co(HONOsar)](3+), form either 1 : 1 or 1 : 2 host-guest inclusion complexes with mono-phosphonium cations and sodium p-sulfonatocalix[4]arene in the solid state yielding complex I [p-sulfonatocalix[4]arene·Co(diCLsar)·2{benzyltriphenylphosphonium}], complex II [2{p-sulfonatocalix[4]arene}·Co(diCLsar)·3{tetraphenylphosphonium}] and complex III [p-sulfonatocalix[4]arene·Co(HONOsar)·tetraphenylphosphonium]. The diversity of the structural types of these multi-component systems, including the orientation of the Co(III) molecules in the cavities of the calixarenes, depends on the nature of their terminal functional groups. The secondary coordination interactions binding between the Co(III) molecules and p-sulfonatocalix[4]arene have also been investigated in water using NMR techniques.
Selective binding of imidazolium cations in building multi-component layers

Ling I, Alias Y, Sobolev AN, Byrne LT, Raston CL

Chemistry, 2010 Jun 18;16(23):6973-82.
PMID: 20455217 DOI: 10.1002/chem.200903320

Addition of 1-alkyl-3-methylimidazolium (C(n)-mim) cations 3-5 to a mixture of bis-phosphonium cation 2 and sodium p-sulfonatocalix[4]arene (1) in the presence of lanthanide ions results in the selective binding of an imidazolium cation into the cavity of the calixarene. The result is a multi-layered solid material with an inherently flexible interplay of the components. Incorporating ethyl-, n-butyl- or n-hexyl-mim cations into the multi-layers results in significant perturbation of the structure, the most striking effect is the tilting of the plane of the bowl-shaped calixarene relative to the plane of the multi-layer, with tilt angles of 7.2, 28.9 and 65.5 degrees , respectively. The lanthanide ions facilitate complexation, but are not incorporated into the structures and, in all cases, the calixarene takes on a 5- charge, with one of the lower-rim phenolic groups deprotonated. ROESY NMR experiments and other (1)H NMR spectroscopy studies establish the formation of 1:1 supermolecules of C(n)-mim and calixarene, regardless of the ratio of the two components, and indicate that the supermolecules undergo rapid exchange on the NMR spectroscopy timescale.
Phase dependent structural perturbation of a robust multicomponent assembled icosahedral array

Ling I, Kumari H, Mirzamani M, Sobolev AN, Garvey CJ, Atwood JL, et al.

Chem Commun (Camb), 2018 Sep 25;54(77):10824-10827.
PMID: 30140821 DOI: 10.1039/c8cc05650a

We report on the assembly of three-fold axially compressed icosahedral arrays of the bowl shaped p-sulfonatocalix[4]arene molecules in the solid-state, intricately bound to dipicolinate and yttrium(iii) ions, with the compression reflected in Hirshfeld surface analyses. Solution studies show dissolution of the icosahedra intact, but with a geometrical rearrangement to regular icosahedra.
Inert Transition Metal Ion Complexes in Organic Synthesis: Protection and Activation

Donnelly PS, Harrowfield JM, Koutsantonis GA, Lengkeek NA, Ling I, Nealon GL, et al.

Chem Asian J, 2023 Sep 15;18(18):e202300556.
PMID: 37442812 DOI: 10.1002/asia.202300556

Single-crystal X-ray diffraction studies for a variety of metal ion complexes of functionalised sarcophagines (sarcophagine=sar=3,6,10,13,16,19-hexa-azabicyclo[6.6.6]icosane) have further confirmed not only that the form of the metal ion/sar unit is unique for each metal, albeit with a sensitivity of the conformation to the associated counter anions, but also that for any given metal and ligand substituent, the dimensions (bond lengths and angles) of the complex and the substituent at the secondary nitrogen centres do not differ significantly from those of the isolated components. Despite this, where the substituent contains reactive sites, the reactivity differs markedly from that of their form in an uncoordinated substrate. Rationalisations are offered for these differences, in part through the use of Hirshfeld surface analysis of the intermolecular interactions. The kinetic inertness of the complexes means that the metal ions can be considered to act as regioselective protecting groups.
Fulltext High shear in situ exfoliation of 2D gallium oxide sheets from centrifugally derived thin films of liquid gallium

Vimalanathan K, Palmer T, Gardner Z, Ling I, Rahpeima S, Elmas S, et al.

Nanoscale Adv, 2021 Oct 12;3(20):5785-5792.
PMID: 36132680 DOI: 10.1039/d1na00598g

A diversity of two-dimensional nanomaterials has recently emerged with recent attention turning to the post-transition metal elements, in particular material derived from liquid metals and eutectic melts below 330 °C where processing is more flexible and in the temperature regime suitable for industry. This has been explored for liquid gallium using an angled vortex fluidic device (VFD) to fabricate ultrathin gallium oxide (Ga2O3) sheets under continuous flow conditions. We have established the nanosheets to form highly insulating material and have electrocatalytic activity for hydrogen evolution, with a Tafel slope of 39 mV dec-1 revealing promoting effects of the surface oxidation (passivation layer).
Fulltext Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: are participants of randomized trials representative of sleep clinic patients?

Reynor A, McArdle N, Shenoy B, Dhaliwal SS, Rea SC, Walsh J, et al.

Sleep, 2022 Apr 11;45(4).
PMID: 34739082 DOI: 10.1093/sleep/zsab264

STUDY OBJECTIVES: Randomized controlled trials (RCTs) have shown no reduction in adverse cardiovascular (CV) events in patients randomized to continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA). This study examined whether randomized study populations were representative of OSA patients attending a sleep clinic.
METHODS: Sleep clinic patients were 3,965 consecutive adults diagnosed with OSA by in-laboratory polysomnography from 2006 to 2010 at a tertiary hospital sleep clinic. Characteristics of these patients were compared with participants of five recent RCTs examining the effect of CPAP on adverse CV events in OSA. The percentage of patients with severe (apnea-hypopnea index, [AHI] ≥ 30 events/h) or any OSA (AHI ≥ 5 events/h) who met the eligibility criteria of each RCT was determined, and those criteria that excluded the most patients identified.
RESULTS: Compared to RCT participants, sleep clinic OSA patients were younger, sleepier, more likely to be female and less likely to have established CV disease. The percentage of patients with severe or any OSA who met the RCT eligibility criteria ranged from 1.2% to 20.9% and 0.8% to 21.9%, respectively. The eligibility criteria that excluded most patients were preexisting CV disease, symptoms of excessive sleepiness, nocturnal hypoxemia and co-morbidities.
CONCLUSIONS: A minority of sleep clinic patients diagnosed with OSA meet the eligibility criteria of RCTs of CPAP on adverse CV events in OSA. OSA populations in these RCTs differ considerably from typical sleep clinic OSA patients. This suggests that the findings of such OSA treatment-related RCTs are not generalizable to sleep clinic OSA patients.Randomized Intervention with Continuous Positive Airway Pressure in CAD and OSA (RICCADSA) trial, https://clinicaltrials.gov/ct2/show/NCT00519597, ClinicalTrials.gov number, NCT00519597.Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients with a First Ever Stroke and Sleep Apnea Syndrome, https://clinicaltrials.gov/ct2/show/NCT00202501, ClinicalTrials.gov number, NCT00202501.Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients with Sleep Apnea and no Daytime Sleepiness, https://clinicaltrials.gov/ct2/show/NCT00127348, ClinicalTrials.gov number, NCT00127348.Continuous Positive Airway Pressure (CPAP) in Patients with Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA) (ISAACC), https://clinicaltrials.gov/ct2/show/NCT01335087, ClinicalTrials.gov number, NCT01335087.
Fulltext Borderless collaboration is needed for COVID-19-A disease that knows no borders

Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, et al.

Infect Control Hosp Epidemiol, 2020 Oct;41(10):1245-1246.
PMID: 32319878 DOI: 10.1017/ice.2020.162
COVID-19 vaccinations: The unknowns, challenges, and hopes

Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, et al.

J Med Virol, 2022 Apr;94(4):1336-1349.
PMID: 34845731 DOI: 10.1002/jmv.27487

The entire world has been suffering from the coronavirus disease 2019 (COVID-19) pandemic since March 11, 2020. More than a year later, the COVID-19 vaccination brought hope to control this viral pandemic. Here, we review the unknowns of the COVID-19 vaccination, such as its longevity, asymptomatic spread, long-term side effects, and its efficacy on immunocompromised patients. In addition, we discuss challenges associated with the COVID-19 vaccination, such as the global access and distribution of vaccine doses, adherence to hygiene guidelines after vaccination, the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, and vaccine resistance. Despite all these challenges and the fact that the end of the COVID-19 pandemic is still unclear, vaccines have brought great hope for the world, with several reports indicating a significant decline in the risk of COVID19-related infection and hospitalizations.